Clinical characteristics and prognosis analysis of patients with de novo ASXL1-mutated AML treated with the C-HUNAN-AML-15 protocol: A multicenter study by the South China Pediatric AML Collaborative Group.
Minhui ZengKeke ChenXin TianRunying ZouXiaoqin FengChunfu LiJian LiMincui ZhengHuirong MaiLihua YangYingyi HeHonggui XuHong WenXiangling HePublished in: Cancer medicine (2023)
/L, but they can benefit from HSCT.